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Gastritis is a histopathologic diagnosis, which correlates poorly with both clin-
ical symptoms of non-ulcer dyspepsia and endoscopic abnormalities.
Worldwide, most cases ofgastritis are due to Helicobacterpylori and are char-
acterized by adiffuse superficial antral gastritis. Chronic inflammatory cells and
lymphoid follicles are present in the lamina propria. Neutrophils are present in
the surface and pit-lining epithelium. In North America and Western Europe,
reactive gastropathy due to duodenal reflux or non-steroidal anti-inflammatory
agents is also common. In this condition, there is no increase in inflammatory
cells, but the pit-lining cells become hyperplastic, and the pits have a corkscrew
appearance. Mostexamples ofmultifocal atrophic gastritis are the result oflong
standing Helicobactergastritis, although there may be other causes as well. It is
characterized by loss ofglands in both pyloric and corpus mucosae with intesti-
nal metaplasia ofthe surface epithelium. A subtype of intestinal metaplasia, in
which sulphomucin (largebowel mucin) is present, has been associated with the
development of distal gastric cancer. However, this association is relatively
weak and is notconsidered useful for screening purposes. Gastric dysplasia may
develop in areas of the stomach affected by intestinal metaplasia. High-grade
dysplasia is a significant finding, with up to 60 percent of cases having coinci-
dent carcinoma and a further 25 percent of cases likely to develop an invasive
malignancy within fifteen months.
CLASSIFICATION OF GASTRITIS
An etio-pathologic classification ofgastritis is given in Table 1. This is derived from
standard textbooks of pathology (1) and some original clinical (2) and morphologic (3)
observations made several years ago. Classifications ofthis type, however, suffer because
they mix entities that are based on a known single etiology with conditions that can only
be described morphologically and may have several causes. These systems are illogical,
but practical in the sense that they may be used as a basis for treatment decisions. With
time, this classification will evolve as more information is gained into the different caus-
es of gastritis.
The recently proposed Sydney system for the classification of gastritis (4) was
intended to replace these mixed and incomplete classifications with one that was both log-
ical and comprehensive. However, it also has faults in that it is not a true classification but
is mainly a device for systematically recording in a logical fashion information of a
descriptive nature. The Sydney system requires that two biopsies be taken from both
pyloric and fundic mucosa and graded at both sites according to the severity of atrophy,
inflammation, activity, intestinal metaplasia and the presence of H. pylori organisms.
Using the Sydney system as it was originally devised may lead to the generation of long
complicated reports suitable for research protocols, but it is confusing to non-experts. It
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Table 1. Classification ofgastritis.
Acute gastritis:
Acute erosive gastritis
Suppurative gastritis
Chronic gastritis:
Helicobacter gastritis
Multifocal atrophic gastritis
Autoimmune gastritis
Granulomatous gastritis
Eosinophilic gastritis
Lymphocytic gastritis
Radiation/Chemotherapy gastritis
Viral gastritis
Graft vs. host disease
Reactive gastropathy
was devised by a committee composed mainly of European pathologists and gastroen-
terologists, but, at the present time, it is not widely used in North America.
REACTIVE GASTROPATHY
Throughout the world, gastritis related to H. pylon infection is by far the most com-
mon cause of inflammation of the stomach, although in North America and Western
Europe a reactive gastropathy secondary to drug therapy, especially non-steroidal anti-
inflammatory agents (5), or duodenal reflux (6) is also frequent. Reactive gastropathy is
thought to be the result ofincreased exfoliation ofcells from the mucosal surface leading
to increased proliferation ofpit-lining cells. This is likely a secondary cytotoxic effect of
drugs or a component of bile, such as lysolethicin. Morphologically, the gastric pits
become elongated and develop a corkscrew appearance (Figure 1). The lining cells show
cytoplasmic mucus depletion and have enlarged nuclei containing prominent nucleoli.
Inflammation ofthe epithelium and the lamina propria is not present, although there may
be capillary dilation giving rise to aprofound congestion that can be endoscopically strik-
ing. This absence of inflammation is probably not surprising, since the pharmacologic
action ofnon-steroidal anti-inflammatory agents is to suppress the inflammatory reaction.
Reactive gastropathy is a chronic condition, which should be distinguished from acute
hemorrhagic gastritis. Hemorrhagic gastritis may also be the result of ingestion of non-
steroidal anti-inflammatory agents, particularly aspirin, and is characterized by the pres-
ence of fresh bleeding into the lamina propria with acute ulcers, usually superficial ero-
sions. Ifulceration occurs in reactive gastropathy, itis usually in the form ofchronic ulcers
that mimic peptic ulcers.
AUTOIMMUNE GASTRITIS
Autoimmune gastritis (the gastritis of pernicious anemia) occurs most commonly in
individuals from Northern Europe, particularly Scandinavia (7). Typically, the corpus and
fundus are most severely affected and develop an extreme degree of atrophy, so that the
glands containing chiefand parietal cells are almost totally destroyed (Figure 2). The sur-
face and pit-lining epithelium undergoes metaplasia to an intestinal pattern. In advanced
disease, there can be formation ofPaneth cells and evenrudimentary villi. Theearly stages
(i.e., pre-atrophic) ofautoimmune gastritis show adense lymphoplasmacytic infiltrate sur-
rounding the oxyntic glands with sparing ofthe superficial mucosa(8). Itis presumed that
the disease progresses by cytotoxic lymphocytes progressively destroying the specialized
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Figure 1. Reactive gastropathy, showing extreme tortuosity of the pits. Inset shows regenera-
tive epithelium.
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Figure 2. Autoimmune gastritis showing extensive intestinal metaplasia with complete loss of
acid and enzyme secreting glands.
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gastric body and fundic glands. Ultimately, the inflammation "bums itself out," leaving a
severely atrophic, but uninflamed mucosa. 'Typically, in autoimmune gastritis, the pyloric
(antral) glands, which are exclusively mucus secreting, are preserved.
HELICOBACTER PYLORI GASTRITIS
The histologic features of the early stages ofH. pylori gastritis are well described (9,
10). The superficial lamina propria is expanded and contains an infiltrate of mature lym-
phocytes andplasma cells. Lymphoid follicles with germinal centers are present, although
these may not be sampled in every biopsy. In active disease, the pit-lining and surface
epithelium is infiltrated by neutrophils, and collections of neutrophils (pit abscesses) may
be present within the lumen of the pits (Figure 3). In general terms, the intensity of the
neutrophilic infiltrate parallels the numbers of organisms present (11). However, active
gastritis is more severe in the antrum than it is in the fundus, although organisms may be
seen at both sites. Thepit-lining cells show a loss ofmucus, often with a scalloping of the
superficial cytoplasm, particularly in heavy infections. The nuclei are enlarged and vesic-
ular with prominent nucleoli. At this stage of the disease, organisms are readily identified
within the surface layer of mucus. They are particularly obvious at the site of intercellu-
larjunctions ofthe surface epithelium. A special stain is rarely needed to identify the bac-
teria, although a number are available (12, 13). They are best used when the initial routine
hematoxylin and eosin stains are negative or for a follow-up biopsy following antibiotic
therapy, when it is necessary to detect possible small numbers ofresidual organisms. Care
should be taken to include as positive only the characteristic slender gull wing shaped
bacilli. A number of fusiform bacilli or cocci may occasionally be encountered, probably
representing contamination from the oropharynx. Other types of Helicobacter that may
rarely be encountered in gastric biopsies include Helicobacter heilmanni (Gastrospirilum
hominis). This can be recognized on special stains as a tightly coiled spiral organism.
After successful treatment with antibiotics, the bacteria and the neutrophilic infiltrate dis-
appear within a matter ofweeks (14). The chronic inflammation persists, at least initially.
In North America, it is unusual to find H.pylori gastritis in children, although in
developing countries it can bepresent in 50percent ofindividuals(15). In North American
adults beyond the age of 60 years, serologic evidence of H.pylori infection is present in
40 to 60 percent of the general population (16). In developing countries, adult infection
may be as high as 70 to 90 percent (15).
MULTIFOCAL ATROPHIC GASTRITIS
Multifocal atrophic gastritis (MAG)b is a controversial diagnosis (17), which is not
recognized by all authorities as a separate nosologic entity. Morphologically, MAG is
characterized as apatchy disease involving both the antrum and the fundus. The changes
are maximal along the lesser curvature in the region of the incisura (18). Histologically,
there is extension of a chronic inflammatory infiltrate to involve the full thickness of the
mucosa with an accompanying gland atrophy. Intestinal metaplasia is exceedingly com-
mon, if not universal (Figure 4). As the glands of the fundic mucosa atrophy, there is a
reduction in acid output (19). Active inflammation, in the form of neutrophil infiltration
ofthe surface and pit-lining epithelium, may or may not occur, depending on whether H.
pylori organisms are present.
At the present time, it seems likely that most cases ofMAG, at least thoseoccurring
in North America and Western Europe, are the result ofongoing H.pylori infection (20).
The time scale for the conversion of an active superficial gastritis to an atrophic gastritis
is unclear, but is probably several years. Many factors may influence this conversion,
including host immunologic response, diet and strains oforganisms of different virulence
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Figure 3. Helicobacter pylon gastritis, showing the presence of reactive lymphoid follicles.
Inset (left): neutrophilic infiltrate ofpit epithelium. Inset (right): organisms on mucosal surface.
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Figure 4. Multifocal atrophic gastritis showing mucosal inflammatory infiltrate with gland
atrophy. Focal intestinal metaplasia is seen (inset).
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(18, 21). The age at which infection is first acquired may also be important. In third-world
countries, MAG is relatively common and is positively associated with the risk ofdevel-
oping gastric cancer (22).
INTESTINAL METAPLASIA
Intestinal metaplasia (IM) occurs almost universally in MAG, but may complicate
other chronic inflammatory conditions also. These include autoimmune gastritis, gastric
Crohn's disease and radiation gastritis. It has been divided into three types (23, 24). Each
ofthese involve achange ofthe normal gastric surface epithelium to intestinal epithelium.
In type I IM (Figure 5a), the stomach comes to resemble the normal small bowel with the
presence of goblet cells and absorptive cells. In advanced cases, there may even be for-
mation ofrudimentary villi, and Paneth cells may be present at the base ofthe crypts. The
mucin within the goblet cells is sialomucin, which stains positive with both periodic acid-
Schiff and alcian blue at pH 2.5.
Type II IM is an incomplete form of type I. The normal neutral mucus ofthe gastric
surface epithelium changes to sialomucin, but the morphology ofthe mucosa is unaltered,
so that no goblet cells are encountered. The change can, therefore, only be detected by
special histochemical stains.
In type III metaplasia (Figure 5b), the mucus component of the epithelium comes to
resemble large bowel mucosa. Gobletcells may be present, butcontain sulphomucin. This
is a highly acidic mucin, which is only weakly periodic acid-Schiff-positive, but may be
identified by staining with alcian blue at pH 0.5, or with a high iron diamine technique.
Intestinal metaplasia of all types has a weak association with the presence of gastric
cancer. The association is stronger for type III IM (25). The risk is most obvious for dis-
tal intestinal type carcinoma and is less for diffuse carcinoma (25, 26). Proximal gastric
carcinoma shares many morphological and epidemiological characteristics with carcino-
ma arising in Barrett's esophagus (27). Although Barrett's esophagus consists of meta-
plastic epithelium, this is distinct from intestinal metaplasia and does not appear to be
related to H. pylon infection. Interestingly, when seropositivity forH. pylon is compared
with the incidence ofgastric cancer, the risk is highest for distal intestinal cancer, less for
diffuse cancer and least for cardiac cancer (28). This seems reasonable, given that large
bowel metaplasia may reasonably be expected to be associated with a large bowel type
carcinoma.
Unfortunately, the simple presence ofsulphomucin in gastric biopsy material cannot
be used as a satisfactory screening method to predict the subsequent development ofcan-
cer. This is because it is a relatively frequent finding in individuals with MAG, most of
whom will never develop malignancy. It remains to be seen, however, whether the extent
ofsulphomucin metaplasia could be combined with other risk factors, such as family his-
tory, to identify certain high-risk individuals.
GASTRIC DYSPLASIA
Dysplasia is ahistopathologic diagnosis. Thechange is neoplastic, but is distinct from
reactive hyperplasia and invasive carcinoma. It almost invariably occurs in stomachs
affectedby atrophic gastritis. Forpractical purposes, it may be subdivided into high-grade
and low-grade. High-grade dysplasia incorporates the term carcinoma-in-situ.
Morphologically, it is characterized by a high degree of nuclear crowding and enlarge-
ment, so that greater than 50 percent ofthe cell is occupied by nucleus. In low-grade dys-
plasia, less than 50 percent ofthe cell volume consists ofnucleus. Adenomas ofthe stom-
ach also contain dysplastic epithelium; however, by convention, use ofthe term dysplasia
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by itself usually implies an ill-defined gross anatomical lesion that is characteristically
non-polypoid.
Dysplasia may, however, be visible endoscopically as a change in the texture of the
surface mucosa often described as velvety in appearance.
Two morphologically distinct types ofgastric dysplasia have been described (29, 30).
The commonest, or type I dysplasia, closely resembles the epithelium within an adenoma.
The dysplastic cells are crowded with pseudostratified cigar-shaped nuclei and abundant
amphophilic cytoplasm (Figure 6). Only small amounts ofmucus are present. Type II dys-
plasia arises in mucosa that may be architecturally abnormal with crowded or branched
glands. Both goblet and columnarcells may be seen. The nuclei areenlarged, rounded and
vesicular with prominent nucleoli. This form of dysplasia is the most difficult to distin-
guish from regenerative changes.
The significance of a diagnosis ofdysplasia is not fully established (29-33). A major
problem is that different investigators have used different criteria for the diagnosis. Not
surprisingly, this has produced different results. High-grade dysplasia is the most easy
Figure 5. Intestinal metaplasia. A: Complete metaplasia with goblet cells and absorptive cells. B:
Incomplete metaplasia. Both goblet cells and columnar cells contain sulphomucin (high iron
diamine stain).
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Figure 6. Low-grade gastric dysplasia. Pits are lined by cells with hyperchromatic cigar shaped
nuclei with loss ofpolarity.
lesion to diagnose, but great care should be exercised in distinguishing it from early inva-
sive carcinoma. The presence of irregularly budding glands or glands with back-to-back
formations raise thepossibility thatearly infiltration ofthe laminapropria may be present.
Low-grade dysplasia is easy to confuse with regenerative changes (Figure 6) and has asig-
nificant interobserver and intraobserver variability. Low-grade dysplasia is a lesion that
may progress, remain the same or even regress (33). High-grade dysplasia is highly sig-
nificant. Up to 60 percent of cases may have a coincident cancer and a further 25 percent
of cases may develop it within 15 months (32). The cancer risk is particularly high when
a gross lesion is visualized endoscopically.
At the present time, it is not known what percentage of intestinal carcinomas are pre-
ceded by gastric dysplasia, or what is the time interval between the first appearance of
dysplasia and the onset of an invasive neoplasm. Most resected carcinomas do not have
adjacent dysplasia, suggesting that if originally present, the zone of dysplasia was small
and was destroyed by the spreading neoplasm. The management ofpatients with gastric
dysplasia is controversial (33, 34). Most people think that high-grade dysplasia should be
treated aggressively. After initial diagnosis, the extent ofthe lesion should be mapped and
all dysplastic areas excised. Mild dysplasia can also be treated in a similar manner (34),
but may result in overtreatment of some individuals. For this reason, some groups (33)
prefer a more conservative approach, with several follow-up biopsies to confirm that there
is a definite persistent abnormality before resection is performed.
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CONCLUSIONS
1. Currently, the clinicopathological classification of gastritis is unsatisfactory, because
the etiology and pathogenesis is not known for many "entities."
2. The histopathological diagnosis ofgastritis correlates poorly with endoscopic findings
and clinical symptoms.
3. Reactive gastropathy is characterized by increased proliferative activity in the gastric
foveolar epithelium. This is a relatively common diagnosis on gastric biopsy and, in
many cases, appears to be the result of ingestion of non-steroidal anti-inflammatory
drugs.
4. Diffuse superficial gastritis, due to infection by H. pylori, is another common cause of
gastritis in North America and Western Europe. In most cases, organisms can readily
be identified in antral biopsies.
5. Autoimmune gastritis is characterized by a diffuse atrophic gastritis involving the fun-
dus with antral sparing. In the late stages of disease, there may be achlorhydria. Loss
ofintrinsic factor results in malabsorption of vitamin B12 and pernicious anemia.
6. Multifocal atrophic gastritis isrelatively rare in NorthAmerica, butis muchmore com-
mon in underdeveloped countries. In most instances, this condition is an end stage of
helicobacter gastritis, but appears to require other factors (dietary or environmental)
for full expression.
7. Both autoimmune gastritis and multifocal atrophic gastritis are characterized histolog-
ically by intestinal metaplasia. This is regarded as a precursor of gastric cancer.
Unfortunately however, the association is not close enough for the presence ofintesti-
nal metaplasia to be used as a screening tool.
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